Intangible Assets and Goodwill (Tables)

6 Months Ended

Jun. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible assets consist of the following ($ in 000’s):

	June 30, 2013
	Gross Amount		Accumulated Amortization			Foreign Currency Translation			Impairment			Net Amount		Weighted Average Amortization Period (years)
ZEVALIN intangibles—US	$	41,900	$	(21,595	)	$	—		$	—		$	20,305		5.5
ZEVALIN intangibles—Ex. US		23,490		(3,604	)		(663	)		—			19,223		8.8
FUSILEV intangibles		16,778		(3,966	)		—			—			12,812		6.5
FOLOTYN license with Mundipharma		27,900		(2,300	)		—			(1,023	)		24,577		9.3
FOLOTYN distribution rights—US & Canada		118,400		—			—			—			118,400		n/a
Melphalan license with CyDex Pharmaceuticals		7,700		—			—			—			7,700		n/a
Total intangible assets	$	236,168	$	(31,465	)	$	(663	)		(1,023	)	$	203,017

Schedule of Goodwill

Goodwill includes the following:

	June 30, 2013			December 31, 2012
	($ in ‘000’s)
Acquisition of Zevalin Rights	$	2,525		$	2,525
Acquisition of Allos		26,485			26,485
Foreign exchange translation effects		(70	)		(37	)
	$	28,940		$	28,973